Trial intelligence / Profile preview

Febuxostat vs allopurinol in gout with hyperuricemia (Phase II)

CTR20130519Phase 2Active

Start
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of febuxostat in gout, hyperuricemia. Started Oct 2013; status: active.

02

Drugs

febuxostat
03

Conditions

gouthyperuricemia

Beyond the preview

Go deeper on CTR20130519.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130519.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call